1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Immunodiagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Immunodiagnostics Market Regional Analysis
6.2 Middle East & Africa Immunodiagnostics Market Revenue 2021-2030 (US$ Million)
6.3 Middle East & Africa Immunodiagnostics Market Forecast Analysis
7. Middle East & Africa Immunodiagnostics Market Analysis – by Product
7.1 Enzyme-Linked Immunosorbent Assays
- 7.1.1 Overview
- 7.1.2 Enzyme-Linked Immunosorbent Assays: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
7.2 Chemiluminescence Immunoassays
- 7.2.1 Overview
- 7.2.2 Chemiluminescence Immunoassays: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
7.3 Radioimmunoassays
- 7.3.1 Overview
- 7.3.2 Radioimmunoassays: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8. Middle East & Africa Immunodiagnostics Market Analysis – by Clinical Indication
8.1 Infectious Diseases
- 8.1.1 Overview
- 8.1.2 Infectious Diseases: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.2 Hepatitis+HIV
- 8.2.1 Overview
- 8.2.2 Hepatitis+HIV: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.3 Endocrinology
- 8.3.1 Overview
- 8.3.2 Endocrinology: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.4 Gastrointestinal
- 8.4.1 Overview
- 8.4.2 Gastrointestinal: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.5 Metabolics
- 8.5.1 Overview
- 8.5.2 Metabolics: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9. Middle East & Africa Immunodiagnostics Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.4 Academic & Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic & Research Institutes: Middle East & Africa Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
10. Middle East & Africa Immunodiagnostics Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East & Africa Immunodiagnostics Market Breakdown, by Key
Country, 2024 and 2030 (%)
- 10.2.1.1 Middle East & Africa Immunodiagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa Immunodiagnostics Market Breakdown, by Product
- 10.2.1.1.2 South Africa: Middle East & Africa Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.1.3 South Africa: Middle East & Africa Immunodiagnostics Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia:
Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa Immunodiagnostics Market Breakdown, by Product
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa Immunodiagnostics Market Breakdown, by End User
- 10.2.1.3 UAE:
Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa Immunodiagnostics Market Breakdown, by Product
- 10.2.1.3.2 UAE: Middle East & Africa Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.3.3 UAE: Middle East & Africa Immunodiagnostics Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Immunodiagnostics Market Breakdown, by Product
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Immunodiagnostics Market Breakdown, by Clinical Indication
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Immunodiagnostics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 bioMerieux SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Danaher Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 DiaSorin SpA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 PerkinElmer Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Siemens Healthcare GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Svar Life Science AB
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations